白质病变的神经病理学、血脑屏障功能障碍与痴呆
在MRC CFAS队列的126名老年人(平均年龄86.4岁)中,利用死后脑组织数字化病理定量血脑屏障功能障碍(纤维蛋白原免疫组化标记)。发现纤维蛋白原沉积与MRI或组织学白质异常无显著关联,但在MRI正常者中与痴呆风险降低相关,在有组织学病变者中与痴呆风险升高相关。
要点
- 血脑屏障功能障碍在老年人中常见,可能独立于标准MRI生物标志物与痴呆风险相关。
- 纤维蛋白原沉积与MRI白质高信号或组织学白质病变无显著关联。
- 在MRI正常者中,纤维蛋白原增加与痴呆风险降低相关;在有组织学病变者中则风险升高。
核心结论
- 血脑屏障功能障碍在老年人中常见,可能附加于标准MRI生物标志物与临床痴呆风险相关。
研究设计与样本
- 基于MRC CFAS队列的横断面死后脑组织研究,纳入126名老年人(平均年龄86.4岁,SD 7.7)。
- 利用数字化病理定量皮层下白质中纤维蛋白原免疫组化标记评估血脑屏障功能障碍。
- 组织样本来自死后T2 MRI显示的白质高信号区、正常表现白质区及MRI正常脑的相应区域。
- 组织学病变用吞噬性小胶质细胞标记物CD68(克隆PGM1)定义。
主要发现
- 纤维蛋白原标记程度与MRI定义的白质异常无显著关联(OR 0.90,95%CI 0.79-1.03,P=0.130)。
- 纤维蛋白原标记程度与组织病理学定义的白质异常无显著关联(OR 0.93,95%CI 0.77-1.12,P=0.452)。
- 在MRI正常(无可检测白质高信号)参与者中,纤维蛋白原增加与临床痴呆风险降低显著相关(OR 0.74,95%CI 0.58-0.94,P=0.013)。
- 在有组织学病变的参与者中,纤维蛋白原增加与痴呆风险升高相关(OR 2.26,95%CI 1.25-4.08,P=0.007)。
临床怎么用
- 血脑屏障功能障碍可能作为老年人痴呆风险的额外生物标志物,尤其需结合MRI白质状态解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: We tested whether blood-brain barrier dysfunction in subcortical white matter is associated with white matter abnormalities or risk of clinical dementia in older people (n=126; mean age 86.4, SD: 7.7 years) in the MRC CFAS (Medical Research Council Cognitive Function and Ageing Study). METHODS: Using digital pathology, we quantified blood-brain barrier dysfunction (defined by immunohistochemical labeling for the plasma marker fibrinogen). This was assessed within subcortical white matter tissue samples harvested from postmortem T2 magnetic resonance imaging (MRI)-detected white matter hyperintensities, from normal-appearing white matter (distant from coexistent MRI-defined hyperintensities), and from equivalent areas in MRI normal brains. Histopathologic lesions were defined using a marker for phagocytic microglia (CD68, clone PGM1). RESULTS: Extent of fibrinogen labeling was not significantly associated with white matter abnormalities defined either by MRI (odds ratio, 0.90; 95% confidence interval, 0.79-1.03; P=0.130) or by histopathology (odds ratio, 0.93; 95% confidence interval, 0.77-1.12; P=0.452). Among participants with normal MRI (no detectable white matter hyperintensities), increased fibrinogen was significantly related to decreased risk of clinical dementia (odds ratio, 0.74; 95% confidence interval, 0.58-0.94; P=0.013). Among participants with histological lesions, increased fibrinogen was related to increased risk of dementia (odds ratio, 2.26; 95% confidence interval, 1.25-4.08; P=0.007). CONCLUSIONS: Our data suggest that some degree of blood-brain barrier dysfunction is common in older people and that this may be related to clinical dementia risk, additional to standard MRI biomarkers.
引用
- Hainsworth AH, Minett T, Andoh J, et al. Neuropathology of White Matter Lesions, Blood-Brain Barrier Dysfunction, and Dementia. Stroke. 2017. PMID: 28855392. doi:10.1161/STROKEAHA.117.018101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。